Keywords: ریتوکسیماب; AAV; ANCA-associated vasculitis; ANCA; antineutrophil cytoplasm antibody; CYP; cyclophosphamide; EULAR; European League Against Rheumatism; GPA; granulomatosis with polyangiitis; MPO; myeloperoxidase; PR3; proteinase 3; RTX; rituximab;
مقالات ISI ریتوکسیماب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریتوکسیماب; Eosinophilic granulomatosis with polyangiitis; Rituximab; Vasculitic neuropathy; Literature review
Keywords: ریتوکسیماب; Thrombotic thrombocytopenic purpura; ADAMTS13; Rituximab; Immunotherapy
Keywords: ریتوکسیماب; biobetter; drug design; molecular modeling; monoclonal antibody; mutation; protein aggregation; rituximab; SAP; stabilization;
Keywords: ریتوکسیماب; Rituximab; Antiphospholipid syndrome; Primary antiphospholipid syndrome; Thrombocytopenia; Heart valve diseaseRituximab; Síndrome antifosfolipídico; Síndrome antifosfolipídico primario; Trombocitopenia; Valvulopatía
Keywords: ریتوکسیماب; cost-effectiveness; follicular lymphoma; lymphoma; maintenance; non-Hodgkin lymphoma; radioimmunotherapy; rituximab;
Keywords: ریتوکسیماب; Obinutuzumab; Rituximab; CD20; CLL; NHL; Type II antibody;
Keywords: ریتوکسیماب; Pemphigus vulgaris; Rituximab; Protocol; Lymphoma; Rheumatoid arthritis; Clinical outcomes;
Keywords: ریتوکسیماب; Chronic lymphocytic leukemia; Rituximab; Cyclophosphamide; Fludarabine; Meta-analysis
Keywords: ریتوکسیماب; Vascular targeting; Mantle cell lymphoma; Immunocytokine; Interleukin-2; Rituximab;
Keywords: ریتوکسیماب; Gastric lymphoma; MALT lymphoma; Helicobacter pylori; Radiotherapy; Chemotherapy; Rituximab;
Keywords: ریتوکسیماب; Hairy cell leukaemia; Purine analogue; Pentostatin; Cladribine; Rituximab; Chemoimmunotherapy; Survival;
Keywords: ریتوکسیماب; Cryoglobulinemia; Cryoglobulinemic; Vasculitis; Rituximab; HCV; Diagnosis; Treatment;
Keywords: ریتوکسیماب; Interstitial lung disease (ILD); Systemic sclerosis (SSc); Cyclophosphamide; Rituximab; Stem cell transplant;
Keywords: ریتوکسیماب; uveal lymphoma; MALT lymphoma; rituximab; uveítis; choroidal infiltrate
Keywords: ریتوکسیماب; Lupus; Vasculitis; Vein occlusion; Rituximab; Antiphospholipid syndromeLupus; Vasculitis; Oclusión venosa; Rituximab; Síndrome antifosfolípido
Keywords: ریتوکسیماب; neuromyelitis optica; monoclonal antibody; rituximab; individualized treatment; pediatric; CD19; anti–aquaporin-4 antibody; NMO-IgG
Keywords: ریتوکسیماب; multiple sclerosis; neuromyelitis optica; demyelinating diseases; rituximab; treatment; devic disease;
Keywords: ریتوکسیماب; Rituximab; Transformed lymphoma; Autologous transplant; Allogeneic transplant
Keywords: ریتوکسیماب; Anti-amphiphysin antibody; Paraneoplastic neurological syndrome; Stiff-person syndrome; Immunotherapy; rituximab;
Keywords: ریتوکسیماب; Autoimmune hematological disease; Hematopoietic stem cell transplantation; Children; Rituximab
Keywords: ریتوکسیماب; Rituximab; Immunodeficiency; Hypogammaglobulinemia; Immunoglobulin replacement therapy; IGRT; B-cell phenotype; Persistent immunodeficiency after treatment with immunomodulatory drug; PITID; AIHA; Autoimmune hemolytic anemia; CLL; Chronic lymphocytic leuk
Keywords: ریتوکسیماب; autoimmune bullous diseases; childhood pemphigus vulgaris; juvenile pemphigus vulgaris; rituximab; CR; complete remission; Dsg; desmoglein; ELISA; enzyme-linked immunosorbent assay; PF; pemphigus foliaceus; PR; partial remission; PV; pemphigus vulgaris;
Keywords: ریتوکسیماب; Extranodal marginal zone lymphoma of mucosal associated lymphoid tissue; Ocular adnexal lymphoma; Radiation; Rituximab
Keywords: ریتوکسیماب; Targeting; RBC; Lymphoma; Rituximab; Depletion
Keywords: ریتوکسیماب; MS; multiple sclerosis; NMO; neuromyelitis optica; NK; natural killer cells; EDSS; expanded disability status scale; WBC; white blood cells; Multiple sclerosis; Demyelinating diseases; Immunology; Rituximab; Monoclonal antibodies; Neuromyelitis optica;
Keywords: ریتوکسیماب; Systemic lupus erythematosus; Rituximab; Systematic review;
Keywords: ریتوکسیماب; Lupus nephritis; Randomized controlled trial; Cyclophosphamide; Mycophenolate mofetil; Azathioprine; Cyclosporine; Rituximab;
Keywords: ریتوکسیماب; Hairy cell leukemia; Purine analogues; Rituximab;
Keywords: ریتوکسیماب; Altered mental status; Anti-thyroid antibodies; Rituximab; Mycophenolate mofetil; Steroid responsive encephalopathy with antithyroid antibodies (SREAT); Nonvasculitic autoimmune meningoencephalitis (NAIM);
Keywords: ریتوکسیماب; Graft loss; Organ rejection; Rituximab; Solid organ transplantation; Treatment-related mortality;
Keywords: ریتوکسیماب; Rituximab; Type 1 diabetes; Epstein-Barr virus; JC virus; BK virus; Cytomegalovirus;
Keywords: ریتوکسیماب; Anti-TNF agents; biological drugs; rituximab; anti-IL6; abatacept;
Keywords: ریتوکسیماب; Anti-GBM disease; Rituximab;
Keywords: ریتوکسیماب; anti-TNF-α agents; azathioprine; biologic agents; cyclophosphamide; dapsone; intravenous immunoglobulin; immunosuppressive agents; methotrexate; mycophenolate mofetil; ocular cicatricial pemphigoid; ocular mucous membrane pemphigoid; rituximab; sulfapyri
Keywords: ریتوکسیماب; lymphoma; primary cutaneous B-cell lymphoma; primary cutaneous diffuse large B-cell lymphoma; primary cutaneous follicle center lymphoma; primary cutaneous marginal zone lymphoma; rituximab; therapy; CBCL; cutaneous B-cell lymphoma; CHOP; cyclophosphamide
Keywords: ریتوکسیماب; Thrombotic thrombocytopenic purpura; ADAMTS13; Plasma exchange; Rituximab; Immunotherapy; Purpura thrombotique thrombocytopénique; ADAMTS13; Ãchanges plasmatiques; Rituximab; Immunothérapie;
Keywords: ریتوکسیماب; IgG4-related pachymeningitis; IgG4-related diseases; methotrexate; rituximab
Keywords: ریتوکسیماب; Autoimmune retinopathy; Nonparaneoplastic; Neoplastic; Rituximab; Electroretinography; Electrophysiology
Keywords: ریتوکسیماب; Opsoclonus–myoclonus syndrome; Rituximab; Single dose; Neuroblastoma
Keywords: ریتوکسیماب; Immune thrombocytopenia; Rituximab; Eltrombopag; Romiplostim; Splenectomy; Thrombosis
Keywords: ریتوکسیماب; Anti-CD20 antibodies; Cataract; Uveitis; Rituximab; Wegener’s; Granulomatosis
Keywords: ریتوکسیماب; Anti-NMDAR encephalitis; Plasmapheresis; Autonomic instability; Rituximab; Cyclophosphamide
Keywords: ریتوکسیماب; Thrombotic thrombocytopenic purpura; ADAMTS13; Clopidogrel; Hemolytic uremic syndrome; Rituximab
Keywords: ریتوکسیماب; Rituximab; Non-Hodgkin's lymphoma; Progressive multifocal leukoencephalopathy
Keywords: ریتوکسیماب; Eosinophilic granulomatosis with polyangiitis; Rituximab; Treatment
Keywords: ریتوکسیماب; B-cell; EBV; Extranodal; Lymphomatoid granulomatosis; Rituximab
Keywords: ریتوکسیماب; cryptococcemia; Cryptococcus neoformans; lymphoma; rituximab
Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience
Keywords: ریتوکسیماب; Autologous stem cell transplantation; Cytosine arabinoside; Methotrexate; Primary central nervous system lymphoma; Rituximab;
Primary biliary cholangitis: Old and novel therapy
Keywords: ریتوکسیماب; Primary biliary cholangitis; Primary biliary cirrhosis; Ursodeoxycholic acid; Obeticholic acid; Fibrates; Budesonide; Rituximab; Ustekinumab; Treatment;